Long-term pharmacologic neuroprotection after birth asphyxia: Where do we stand?

Neonatology

Volumn 94, Issue 3, 2008, Pages 203-210

  Van Bel, Frank ^a   Groenendaal, Floris ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Birth asphyxia; Long term neuroprotection

Indexed keywords

2 IMINOBIOTIN; 7 NITROINDAZOLE; ALLOPURINOL; AMINOGUANIDINE; BETAMETHASONE; BIOTIN DERIVATIVE; CARNITINE; DEFEROXAMINE; ERYTHROPOIETIN; FREE RADICAL; FUROSEMIDE; INDOMETACIN; MAGNESIUM SULFATE; MANNITOL; NEUROTRANSMITTER; NEUROTROPIC AGENT; NICARDIPINE; PENTOBARBITAL; PHENOBARBITAL; UNCLASSIFIED DRUG; XENON;

CALCIUM TRANSPORT; EXPERIMENTAL RAT; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; HYPOTHERMIA; INDUCED HYPOTHERMIA; INFLAMMATION; LONG TERM CARE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PERINATAL ASPHYXIA; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA NEONATORUM; BRAIN; BRAIN DISEASES; HUMANS; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS; REPERFUSION INJURY;

EID: 53549126323     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000143723     Document Type: Review

References (77)

1. Glass MC, Ferriero DM: Treatment of hypoxic-ischemic encephalopathy in newborns. Curr Treat Options Neurol 2007;9:414-423.
2. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, Meiners LC, Dubowitz LM, de Vries LS: Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 2003;361:736-742.
3. Gilland E, Puka-Sundvall M, Andiné P, Bona E, Hagberg H: Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Brain Res Dev Brain Res 1994;83:79-84.
4. Ferriero DM: Neonatal brain injury. N Engl J Med 2004;351:1985-1995.
5. Fellman V, Raivo KO: Reperfusion injury as a mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997;41:599-606.
6. Towfighi J, Mauger D: Temporal evolution of neuronal changes in cerebral hypoxia-ischemia in developing rats: a quantitative light microscopic study. Brain Res Deve Brain Res 1998;109:169-177.
7. Hope PL, Costello AM, Cady EB, Delpy DT, Tofts PS, Chu A, Hamilton PA, Reynolds EOR, Wilkie DR: Cerebral energy metabolism studied with phosphorous NMR spectroscopy in normal and birth asphyxiated infants. Lancet 1984;8399:366-370.
8. Lorek A, Takei Y, Cady EB, et al: Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorous magnetic resonance spectroscopy. Pediatr Res 1994;36:699-706.
9. Peeters-Scholte C, Koster J, Veldhuis W, van den Tweel ER, Zhu C, Kops N, Blomgren K, Bar D, van Buul-Offers S, Hagberg H, Nicolay K, van Bel F, Groenendaal F: Neuroprotection by selective nitric oxide synthase inhibition at 24 h after perinatal hypoxiaischemia. Stroke 2002;33:2304-231
10. Peeters-Scholte C, Braun K, Koster J, Kops N, Blomgren K, Buonocore G, Buul-Offers S, Hagberg H, Nicolay K, van Bel F, Groenendaal F: Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 2003;54:516-522.
11. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005;58:182-193.
12. Mishra OP, Delivoria-Papadopoulos M: Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia. Brain Res Dev Brain Res 1989;45:129-135.
13. Ioroi T, Yonetani M, Nakamura H: Effects of hypoxia and reoxygenation on nitric oxide production and cerebral blood flow in developing rat striatum. Pediatr Res 1998;43:733-737.
14. Lievre V, Becuwe P, Bianchi A, Koziel V, Franck P, Schroeder H, Nabet P, Dauca M, Daval JL: Free radical production and changes in superoxide dismutases associated with hypoxia/reoxygenation-induced apoptosis of embryonic rat forebrain neurons in culture. Free Radic Biol Med 2000;29:1291-1301.
15. Bagenholm R, Nilsson UA, Kjellmer I: Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res 1997;773:132-138.
16. Saugstad OD: Oxidative stress in the newborn: a 30 year perspective. Biol Neonate 2005;88:228-236.
17. Bagenholm R, Nilsson UA, Gotborg CW, Kjellmer I: Free radicals are formed in the brain of fetal sheep during reperfusion after cerebral ischemia. Pediatr Res 1998;43:271-275.
18. Shadid M, Buonocore G, Groenendaal F, Moison R, Ferrali M, Berger HM, van Bel F: Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 1998;248:5-8.
19. McGowan JE, McGowan JC, Mishra OP, Delivoria-Papadopoulos M: Effect of cyclo-oxygenase inhibition on brain cell membrane lipid peroxidation during hypoxia in newborn piglets. Biol Neonate 2004;66:367-375.
20. Mishra OP, Zanelli S, Ohnishi ST, Delivoria-Papadopoulos M: Hypoxia-induced generation of nitric oxide free radicals in cerebral cortex of newborn guinea pigs. Neurochem Res 2000;25:1559-1565.
21. Saugstad OD: Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996;98:103-107.
22. Moorhouse PC, Grootveld M, Halliwell B, Quilan JG, Gutteridge JM: Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987;23:23-28.
23. Palmer C, Tofighi J, Roberts RL, Heitjan DF: Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33:405-411.
24. Gutteridge JM, Richmond R, Halliwell B: Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J 1979;184:469-472.
25. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
26. Kartikasari AE, Georgiou NA, Visseren FL, Kats-Renaud H, Sweder VA, Marx JJ: Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J 2006;20:353-355.
27. Mu D, Chang YS, Vexler ZS, Ferriero DM: Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 2005;195:407-415.
28. Vangeison G, Carr D, Federoff HJ, Rempe DA: The good, the bad and the cell type-specific roles of hypoxia inducible factor-1α in neurons and astrocytes. J Neurosci 2008;28:1988-1993.
29. Rogalska J, Danielisova V, Caputa M: Effect of neonatal body temperature on postanoxic, potentially neurotoxic iron accumulation in the rat brain. Neurosci Lett 2006;393:249-254.
30. Palmer C, Roberts RL, Bero C: Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 1994;25:1039-1045.
31. Delemos RA, Roberts RJ, Coalson JJ, Delemos JA, Null DM, Gerstmann DR: Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline-membrane disease. Am J Dis Child 1990;144:915-919.
32. Reiter CD, Teng RJ, Beckman JS: Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 2000;275:32460-32466.
33. Higuchi Y, Hattori H, Kume T, Tsuji M, Akaike A, Furusho K: Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 1998;342:47-49.
34. Cooper CE: Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector? Trends Biochem Sci 2002;27:33-39.
35. Brown GC, Bal-Price A: Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003;27:325-355.
36. Ferreiro DM, Holtzman DM, Black SM, Sheldon RA: Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 1996;3:64-71.
37. van den Tweel ERW, Peeters-Scholte CMPCD, Van Bel F, Heijnen CJ, Groenendaal F: Inhibition of nNOS and iNOS following hypoxia-ischemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain. Dev Neurosci 2002;24:389-395.
38. van den Tweel ERW, Nijboer C, Kavelaars A, Heijnen CJ, Groenendaal F, Van Bel F: Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxiaischemia in the neonatal rat brain. J Neuroimmunol 2005;167:64-71.
39. van den Tweel ER, van Bel F, Kavelaars A, Peeters-Scholte CM, Haumann J, Nijboer CH, Heijnen CJ, Groenendaal F: Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats . J Cereb Blood Flow Metab 2005;25:67-74.
40. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, Van Bel F, Heijnen CJ: Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab 2006;27:282-292.
41. Matsumori Y, Hong SM, Aoyama K, Fan Y, Kayama T, Sheldon RA, Vexler ZS, Ferriero DM, Weinstein PR, Liu J: Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J Cereb Blood Flow Metab 2005;25:899-910.
42. Sola A, Wen TC, Hamrick SE, Ferriero DM: Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 2005;57:110R-117R.
43. Van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F: Neuroprotective propterties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia-ischemia. Brain Res 2008; in press.
44. Yin W, Cao G, Johnnides MJ, Signore AP, Luo Y, Hickey RW, Chen J: TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol Dis 2006;21:358-371.
45. Calvert JW, Zhou C, Nanda A, Zhang JH: Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. J Appl Physiol 2003;95:2072-2080.
46. Van den Tweel ER, Kavelaars A, Lombardi MS, Groenendaal F, May M, Heijnen CJ, van Bel F: Selective inhibition of nuclear factor (-kappa) B activation after hypoxia-ischemia in neonatal rats is not neuroprotective. Pediatr Res 2006;59:232-236.
47. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A: A dual role of the NF-κB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008; in press.
48. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A: Strong neuroprotection by inhibition of NF-κB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008;39:2129-2137.
49. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J: Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996;16:578-584.
50. Scheepens A, Wassink G, Blanco CE: The effect of a global birth asphyxia on the ontogeny of BDNF and NGF protein expression in the juvenile brain. Brain Res Dev Brain Res 2003;140:215-221.
51. Skoff RP, Bessert D, Barks JD, Silverstein FS: Plasticity of neurons and glia following neonatal hypoxic-ischemic brain injury in rats. Neurochem Res 2007;32:331-342.
52. Ong J, Plane JM, Parent JM, Silverstein FS: Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat. Pediatr Res 2005;58:600-606.
53. Sola A, Wen TC, Hamrick SE, Ferriero DM: Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 2005;57:110R-117R.
54. Juul S: Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr Suppl 2002;91:36-42.
55. Sola A, Rogido M, Lee BH, Genetta T, Wen TC: Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signalling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 2005;57:481-487.
56. Wang CH, Liang CL, Huang LT, Liu JK, Hung PH, Sun A, Hung KS: Single intravenous injection of marked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats. Biochem Biophys Res Commun 2004;314:1064-1071.
57. Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A: Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 2006;139:803-811.
58. Cockburn F, Daniel SS, Dawes GS, James LS, Myers RE, Nienann W, Rodriguez DC, Ross BB: The effect of pentobarbital anesthesia on resuscitation and brain damage in fetal rhesus monkeys asphyxiated on delivery. J Pediatr 1969;75:281-291.
59. Wainwright MS, Mannix MK, Brown J, Stumpf DA: L-Carnitine reduces brain injury after hypoxia-ischemia in newborn rats. Pediatr Res 2003;54:688-695.
60. Dohlen G, Odland HH, Carlsen H, Blomhoff R, Thaulow E, Saugstad OD: Antioxidant activity in the newborn brain: a luciferase mouse model. Neonatology 2008;93:125-131.
61. Andresen JH, Solberg R, Loberg EM, Munkeby BH, Stray-Pedersen B, Saugstad OD: Resuscitation with 21 or 100% oxygen in hypoxic nicotine-pretreated newborn piglets: possible neuroprotective effects of nicotine. Neonatology 2008;93:36-44.
62. Adhikari M, Moodley M, Desai PK: Mannitol in neonatal cerebral oedema. Brain Dev 1990;12:349-351.
63. Svenningsen NW, Blennow G, Lindroth M, Gaddlin PO, Ahlstrom H: Brain-orientated intensive care treatment in severe neonatal asphyxia: effects of phenobarbitone protection. Arch Dis Child 1982;57:176-183.
64. Hall RT, Hall FK, Daily DK: High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998;132:345-348.
65. Levene MI, Gibson NA, Fenton AC, Papathoma E, Barnett D: The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol 1990;32:567-574.
66. Groenendaal F, Rademaker CMA, Toet MC, de Vries LS: Effects of magnesium sulfate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr 2002;91:1073-1077.
67. Ichiba H, Yokoi T, Tamai H, Ueda T, Kim TJ, Yamano T: Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate. Pediatr Int 2006;48:70-75.
68. Van Bel F, Shadid M, Moison RMW, Dorrepaal CA, Fontijn J, Monteiro L, Van de Bor M, Berger HM: Effect of allopurinol on post-asphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185-193.
69. Benders MJ, Bos AF, Rademaker CM, Rijken M, Torrance HL, Groenendaal F, Van Bel F: Early postnatal allopurinol does not improve short-term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 2006;91:F163-F165.
70. Gunes T, Ozturk MA, Koklu E, Kose K, Gunes I: Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns. Pediatr Neurol 2007;36:17-24.
71. Boda D, Németh I, Kiss P, Orvos H: Treatment of mothers with allopurinol to produce therapeutic blood levels in newborns. Prenat Neonat Med 1999;4:130-134.
72. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-670.
73. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1574-1584.
74. Azzopardi D, Edwards AD: Hypothermia. Semin Fet Neon Med 2007;12:303-310.
75. Barks JDE: Current controversies in hypothermic neuroprotection. Semin Fet Neon Med 2008;13:30-34.
76. Heffron T, Pillew T, Welch D, et al: Medical and surgical treatment of neonatal haemochromatosis: single center experience. Pediatr Transplant 2007;11:374-378.
77. Ferriero DM: Timing is everything: delaying therapy for delayed cell death. Dev Neurosci 2002;24:349-351.